Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1075 results for "pharma trading company"

RPG Life ends 8% higher; buys 7 brands from Sun Pharma
India Infoline

RPG Life ends 8% higher; buys 7 brands from Sun Pharma

RPG Life Sciences closed 8.14% higher at Rs.381.20 on BSE after the company announced that it has acquired 7 brands from Sun Pharma. The company yesterday said that it has signed an agreement to acquire seven prescription brands from Sun ... India Infoline, 16 hours ago

32 images for pharma trading company

India Infoline, 21 hours ago
India Infoline, 22 hours ago
Bio Spectrum Asia, 1 week ago
Ticker Report, 3 weeks ago
Financial Express, 4 weeks ago
livemint.com, 1 month ago
Ticker Report, 1 month ago
Yahoo! Canada, 2 months ago
Business Standard, 1 month ago
RTTNews.com, 1 month ago
India Infoline

Sun Pharma rises 2% on the back of deal with Polaris in Europe

Sun Pharma closed 1.9% higher at Rs.823.80 on BSE after the company signed a deal in Europe with Polaris. Sun Pharma and its wholly owned subsidiary and Almirall announced a licensing agreement on the development and commercialization of ...
 India Infoline16 hours ago Sun Pharma surges 2%; inks pact in Europe with Polaris  India Infoline21 hours ago
Financial Express

Glenmark Pharma gains after receiving USFDA approval for a drug

Glenmark Pharmaceuticals rose 0.77% to Rs 849.60 at 10:45 IST on BSE after the company announced that its US subsidiary received final approval from the US drug regulator for a drug. The announcement was made before market hours today, 27 July ...
 Capital Market1 day ago Glenmark Pharma dips 1% despite FDA nod; raises US$ 200 mn  India Infoline2 days ago Glenmark ends marginally lower; gets FDA nod for Triamcinolone Acetonide Ointment  India Infoline3 days ago Glenmark Pharma gets USFDA approval for Triamcinolone Acetonide ointment  MyIris3 days ago
[x]  
DNA

Sun Pharma Q4 profit jumps two-fold to Rs 1,713.69 crore

Despite the jump in net profits, the company's shares were trading nearly 3% down on Tuesday morning.
 DNA1 month ago Dr Reddy's Labs Q1 net profit plunge 76% yoy on US woes, shares drop 4%  Financial Express2 days ago Dr. Reddy's slumps nearly 10% on weak Q1 numbers  MSN News US1 day ago Dr. Reddy's Labs slumps nearly 10 per cent on weak Q1 numbers, should you invest?  Financial Express1 day ago

Benchmark indices edge higher for 4th straight trading session

Stocks of public sector banks, pharma companies, crude oil refiners and index heavyweights Infosys and HDFC led the latest upmove on the bourses. The barometer index, the S BSE Sensex, rose 298.17 points or 1.13% to 26,664.85, as per the provisional closing ...
 Business Standard2 months ago
Livemint.com

Sun Pharma gains after signing licensing agreement with Almirall for drug

Sun Pharmaceutical Industries rose 0.53% to Rs 812 at 10:35 IST on BSE after the company and Almirall announced a licensing agreement on the development and commercialization of tildrakizumab for psoriasis in Europe. The announcement was made ...
 Capital Market20 hours ago Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis  Equity Bulls1 hour ago Sun Pharma, Almirall enter pact for psoriasis novel biologic  Times of India19 hours ago Sun Pharmaceutical gains on pact with Almirall for Psoriasis drug  Smart Investor21 hours ago
[x]  
Fortune

China's Fosun Just Paid $1.4 Billion for This KKR-Backed Company

Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma backed by KKR & Co LP for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound acquisition this year. The deal, which the ...
 Fortune15 hours ago REFILE-BRIEF-Shanghai Fosuns unit to acquire stake in KKR-backed Gland Pharma from India  Reuters UK14 hours ago Fosun Pharma To Buy Gland Pharma for Up to $1.26 Billion  Bloomberg15 hours ago Fosun Agrees To Buy Gland Pharma For $1.4 Billion  Businessworld India21 hours ago
[x]  
Livemint.com

Teva expect to close $40.5B Allergan generic deal next week

Shares of Teva Pharamaceuticals (TEVA) are advancing 0.24% to $55.28 this morning after the Israeli pharmaceuticals company received clearance from the Federal Trade Commission to purchase Allergan's (AGN) generics business. The $40.5 billion ...
 Equilibrio Informativo3 hours ago Cipla, Aurobindo Pharma acquire products divested by Teva in US  Livemint.com10 hours ago US regulators just gave the green light for Teva's multibillion-dollar purchase of Allergan's generics business  Business Insider1 day ago Teva, Allergan win U.S. antitrust approval for generics deal  Sharenet1 day ago
[x]  

Torrent Pharma ends 2% higher, despite poor Q1 results

Shares of the Ahmedabad-based Torrent Pharma ended 1.8% higher at Rs.1,435.65 on BSE despite the company reporting dismal financial numbers for the quarter ended June 30. The drug major has posted a net profit of Rs.337 crore for Q1 FY17 as ...
 India Infoline16 hours ago Torrent Pharma plunges 1% on disappointing Q1 results  India Infoline21 hours ago Torrent Pharma Profit Falls 55% In Q1, Shares Hit  NDTV23 hours ago Torrent Pharma net declines 60 per cent in Q1  ProKerala.com1 day ago
[x]  
Rediff.com

Markets end flat amid volatile trade; Lupin up 6%

Pharma shares were the top gainers led by Lupin after the company received EIR from USFDA for its Goa facility
 Business Standard3 weeks ago Lupin receives USFDAs tentative nod for Lexiva tablets  MyIris8 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less